Welcome to our dedicated page for Empower Clinics news (Ticker: EPWCF), a resource for investors and traders seeking the latest updates and insights on Empower Clinics stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Empower Clinics's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Empower Clinics's position in the market.
Empower Clinics Inc. (OTCQB: EPWCF) has launched COVID-19 RT-PCR testing through its Sun Valley Health operations, facilitated by Kai Medical Laboratory. This initiative, part of a 'Back to Work' and 'Back to School' campaign, aims to address the increasing demand for testing as schools and businesses reopen. With the capacity to process over 2,000 tests in an eight-hour shift, results are available within 24 to 48 hours. Empower's strategic marketing campaigns aim to enhance awareness and drive testing volume as part of a broader nationwide testing initiative.
Empower Clinics has announced plans to acquire Kai Medical Laboratory, a CLIA and COLA accredited diagnostics lab in Dallas, TX. The acquisition aims to enhance COVID-19 testing capabilities across the U.S. Kai Medical currently conducts over 2,000 RT-PCR tests per day and has developed programs for direct-to-consumer testing and an Employer COVID-19 Compliance Program. The deal involves a total transaction value exceeding $1,750,000 and the assumption of various liabilities. Closing is expected by October 15, 2020, pending due diligence and regulatory approvals.